Related content

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study

By Kilicdag Esra Bulgan   Bagis Tayfun   Zeyneloglu Hulusi B.   Tarim Ebru   Aslan Erdogan   Haydardedeoglu Bulent   Erkanli Serkan  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 894-899

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial

By Fux Otta CarolinaFux   Wior Myriam   Iraci Gabriel S.   Kaplan Raquel   Torres Diana   Gaido María Isabel   Wyse Eduardo P.  

Gynecological Endocrinology, Vol. 26, Iss. 3, 2010-03 ,pp. : 173-178

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

By Costello Michael F.   Shrestha Bhushan   Eden John   Johnson Neil P.   Sjoblom Peter  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1200-1209

Oxford University Press

Access to resources Recommend Favorite